Breaking News Instant updates and real-time market news.

VOYA

Voya Financial

$50.96

-1.41 (-2.69%)

, PFG

Principal Financial

$51.56

-2.03 (-3.79%)

07:19
06/03/19
06/03
07:19
06/03/19
07:19

Citi recommends focusing on pair trades in Life Insurance

Citi analyst Suneet Kamath believes investors should consider pair trades within the U.S. Life & Health Insurance space. The analyst favors Voya Financial (VOYA) over Principal Financial Group (PFG), Lincoln National (LNC) over Brighthouse Financial (BHF), and Reinsurance Group (RGA) over Aflac (AFL).

VOYA

Voya Financial

$50.96

-1.41 (-2.69%)

PFG

Principal Financial

$51.56

-2.03 (-3.79%)

LNC

Lincoln National

$59.46

-2.28 (-3.69%)

BHF

Brighthouse Financial

$35.49

-1.59 (-4.29%)

RGA

Reinsurance Group

$148.03

-0.275 (-0.19%)

AFL

Aflac

$51.31

-0.27 (-0.52%)

  • 06

    Jun

  • 12

    Jun

  • 13

    Jun

  • 26

    Jul

VOYA Voya Financial
$50.96

-1.41 (-2.69%)

05/09/19
RBCM
05/09/19
NO CHANGE
Target $60
RBCM
Outperform
Voya Financial price target raised to $60 from $55 at RBC Capital
RBC Capital analyst Mark Dwelle raised his price target on Voya Financial to $60 and kept his Outperform rating after its Q1 earnings beat, saying that while the retail investment management flows remained negative, the management discussed a "robust pipeline of new and generally higher fee products." The analyst is positive on the company's prospects for the back half of 2019 and believes that its retirement and investment management business thus far in 2019 has only been constrained by market effects.
03/26/19
FBCO
03/26/19
NO CHANGE
Target $66
FBCO
Outperform
Voya Financial price target raised to $66 from $59 at Credit Suisse
Credit Suisse analyst Andrew Kligerman raised his price target for Voya Financial to $66 from $59 after meeting with the company's management. The analyst notes that management appeared comfortable with 2019-2021 guidance of 10%-plus annual EPS growth and ROE of 13%-15%. Kligerman reiterates an Outperform rating on the shares.
02/05/19
UBSW
02/05/19
DOWNGRADE
Target $45
UBSW
Sell
Principal Financial downgraded to Sell from Neutral at UBS
UBS analyst John Nadel downgraded Principal Financial Group (PFG) to Sell and lowered his price target for the shares to $45 from $46. Consensus estimates remain too high and do not appropriately reflect seasonal weakness typical of Principal's Q1 results, Nadel tells investors in a research note. The analyst views the shares as "currently overvalued" given the company's market pressures in the nearer term and competitive dynamics over the longer term. He prefers shares of Ameriprise Financial (AMP) and Voya Financial (VOYA) to Principal Financial.
01/08/19
01/08/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Voya Financial (VOYA) upgraded to Buy from Neutral at Goldman Sachs analyst Alex Scott saying the company is well positioned to manage through the pullback in equity markets and still hit its targets of 10%-plus earnings growth. 2. Cheesecake Factory (CAKE) upgraded to Outperform from Market Perform at Raymond James with analyst Brian Vaccaro citing better than expected industry sales. 3. Union Pacific (UNP) upgraded to Outperform from Market Perform at Cowen, to Outperform from Sector Perform at RBC Capital and Scotiabank, and to Buy from Neutral at Seaport Global. 4. Monster Beverage (MNST) upgraded to Buy from Hold at SunTrust with analyst William Chappell saying after the recent declines in input costs and the "successful U.S. pricing actions," consensus expectations for the stock are too low, while the concerns over its partnership with Coca-Cola (KO) and challenges around growth in China are "overblown." 5. Molina Healthcare (MOH) upgraded to Overweight from Neutral at both JPMorgan and MUFG. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
PFG Principal Financial
$51.56

-2.03 (-3.79%)

04/29/19
RBCM
04/29/19
NO CHANGE
Target $55
RBCM
Sector Perform
Principal Financial price target raised to $55 from $49 at RBC Capital
RBC Capital analyst Mark Dwelle raised his price target on Principal Financial to $55, saying its Q1 results exceeded expectations in terms of cash flows in all units and "strong sales". The analyst is keeping his Sector Perform rating however, citing the impact of corporate expenses that contributed to earnings declines relative to last year's Q1 across all units.
01/09/19
EVER
01/09/19
DOWNGRADE
Target $48
EVER
In Line
Principal Financial downgraded to In Line from Outperform at Evercore ISI
As reported earlier Evercore ISI analyst Thomas Gallagher downgraded Principal Financial to In Line and lowered his price target to $48 from $58 as part of his broader research note on US and Global Life insurers. The analyst notes that the stock trades at a modest premium based on his 10.5-times forward free cash flow estimate multiple, saying that its valuation is looks "full". Gallagher cites a "potential catalyst" for Principal Financial would be a "recovery in asset management and life insurance valuations" but sees its risk/reward on a relative basis as "properly balanced."
01/09/19
EVER
01/09/19
DOWNGRADE
EVER
In Line
Principal Financial downgraded to In Line from Outperform at Evercore ISI
LNC Lincoln National
$59.46

-2.28 (-3.69%)

01/09/19
LEHM
01/09/19
NO CHANGE
LEHM
Barclays downgrades Life Insurance sector to Neutral from Positive
Barclays analyst Jay Gelb downgraded the U.S. Life Insurance sector to Neutral from Positive because he doubts valuations will improve in a volatile environment. A sub-3% yield on 10-year Treasuries, a flat yield curve, declining equity markets and long-term care insurance risks are viewed as factors in the "substantial de-rating of life insurer valuations," Gelb tells investors in a research note. The analyst prefers the Property and Casualty sector based on its "lower beta and less exposure to a volatile macro environment." As part of the sector rating change, the analyst upgraded Ameriprise Financial (AMP) to Overweight from Equal Weight. He also continues to see value in Prudential (PRU), Unum Group (UNM) and Lincoln National (LNC). His Underweight rated names are Brighthouse Financial (BHF) and Torchmark (TMK).
01/08/19
WELS
01/08/19
INITIATION
Target $63
WELS
Market Perform
Lincoln National resumed with a Market Perform at Wells Fargo
Wells Fargo analyst Elyse Greenspan resumed coverage of Lincoln National with a Market Perform rating and $63 price target. The analyst thinks the stock's risk/reward is neutral given its "higher beta and market sensitivity compared to peers."
05/02/19
JPMS
05/02/19
NO CHANGE
JPMS
Overweight
Lincoln National risk/reward attractive after earnings upside, says JPMorgan
JPMorgan analyst Jimmy Bhullar says Lincoln National's Q1 results affirmed his bullish view on the shares. The quarter was marked by upside in earnings and "healthy" business fundamentals, Bhullar tells investors in a research note. He sees an attractive risk/reward on Lincoln National shares and keeps an Overweight rating on the name with a $92 price target.
04/04/19
SBSH
04/04/19
DOWNGRADE
Target $35
SBSH
Sell
Citi downgrades Brighthouse to Sell, continues to prefer Lincoln National
Citi analyst Suneet Kamat downgraded Brighthouse Financial to Sell from Neutral and lowered his price target for the shares to $35 from $39. The recent decline in long-term interest rates and the forward curve could negatively impact Brighthouse's ability to generate free cash flow from its variable annuity business, Kamat tells investors in a research note. The analyst re-based his base case for the stock and continues to prefer shares of Lincoln National (LNC) over Brighthouse Financial.
BHF Brighthouse Financial
$35.49

-1.59 (-4.29%)

04/04/19
04/04/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Micron (MU) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Joseph Moore saying the company's fundamentals have not changed but the stock has rallied amid recent optimism as cloud demand has started to come back and a competitor has experienced a "minor product qualification challenge." 2. Brighthouse Financial (BHF) downgraded to Sell from Neutral at Citi with analyst Suneet Kamat saying the recent decline in long-term interest rates and the forward curve could negatively impact Brighthouse's ability to generate free cash flow from its variable annuity business. 3. Altaba (AABA) downgraded to Neutral from Overweight at JPMorgan with analyst Douglas Anmuth saying Altaba yesterday announced its board approved plans for a voluntary liquidation and dissolution, with total distributions paid expected between $76.62 and $79.22 per share, which represents ~5-9% upside from current levels. 4. Comerica (CMA) downgraded to Neutral from Overweight at JPMorgan and to Neutral from Buy at Goldman Sachs. 5. Roku (ROKU) downgraded to Neutral from Buy at Guggenheim with analyst Michael Morris saying Apple's (AAPL) video product unveiled on March 25 represents an additional risk to Roku's active user base. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/07/19
03/07/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. United Natural Foods (UNFI) downgraded to Sell from Hold at Pivotal Research with analyst Ajay Jain saying the potential for more disappointment remains following "continued operational setbacks" related to the Supervalu acquisition. 2. AB InBev (BUD) downgraded to Sector Perform from Top Pick at RBC Capital with analyst James Jones saying without further "transformational" acquisitions," AB InBev is unlikely to see incremental margin growth. 3. Toll Brothers (TOL) and Meritage Homes (MTH) were downgraded to Underweight from Neutral at JPMorgan. 4. Brighthouse Financial (BHF) downgraded to Hold from Buy at Sandler O'Neill with analyst John Barnidge saying the stock has been the best performing life insurer in its peer group year-to-date. Stating that his downgrade is not a valuation call. 5. Pengrowth (PGH) downgraded to Underperform from Sector Perform at National Bank. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/04/19
SBSH
04/04/19
DOWNGRADE
Target $35
SBSH
Sell
Brighthouse Financial downgraded to Sell from Neutral at Citi
Citi analyst Suneet Kamat downgraded Brighthouse Financial to Sell from Neutral and lowered his price target for the shares to $35 from $39.
RGA Reinsurance Group
$148.03

-0.275 (-0.19%)

06/27/18
FBCO
06/27/18
NO CHANGE
Target $155
FBCO
Neutral
Reinsurance Group price target lowered to $155 from $164 at Credit Suisse
Credit Suisse analyst Andrew Kligerman lowered his price target for Reinsurance Group to $155 from $164 on valuation. The analyst reiterates a Neutral rating on the shares.
12/11/18
RBCM
12/11/18
UPGRADE
RBCM
Outperform
Reinsurance Group upgraded to Outperform from Sector Perform at RBC Capital
07/30/18
KBWI
07/30/18
UPGRADE
Target $165
KBWI
Outperform
Reinsurance Group upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Ryan Krueger upgraded Reinsurance Group of America to Outperform with an unchanged price target of $165. The 12% pullback in shares year-to-date provides a good entry point in a "quality company," Krueger tells investors in a research note. He views Reinsurance Group as "well-run global reinsurance leader with solid mid-to-high single-digit growth" that offers capital deployment upside and defensive characteristics. This story corrects the price target to $165.
12/11/18
RBCM
12/11/18
UPGRADE
Target $165
RBCM
Outperform
Reinsurance Group upgraded to Outperform from Sector Perform at RBC Capital
As reported earlier, RBC Capital analyst Kenneth Lee upgraded Reinsurance Group to Outperform and raised his price target to $165 from $150. The analyst is positive on the company's "competitive position as one of the largest global life reinsurers", along with its role as the only "pure-play publicly-traded U.S. life reinsurer". Lee also cites Reinsurance Group's "experienced management team with expertise in assessing/pricing reinsurance risks" along with its "very attractive" valuation.
AFL Aflac
$51.31

-0.27 (-0.52%)

10/03/18
JPMS
10/03/18
NO CHANGE
JPMS
JPMorgan sees attractive risk/rewards for life insurance stocks
Life insurance stocks offer attractive risk/reward profiles at current share levels, JPMorgan analyst Jimmy Bhullar tells investors in a research note. The analyst, who's been cautious on the sector for the past two years, says that while his fundamental view "remains mixed," the macro environment has improved, investor sentiment has become negative, and valuation levels are more reasonable following the group's significant underperformance. He maintains Overweight ratings on Aflac (AFL), Lincoln National (LNC), and Prudential (PRU) and reiterates his negative stance on Brighthouse Financial (BHF).
02/04/19
RHCO
02/04/19
NO CHANGE
Target $48
RHCO
Hold
Aflac price target raised to $48 from $44 at SunTrust
SunTrust analyst Mark Hughes raised his price target on Aflac to $48 after its Q4 earnings beat, also raising his FY19 EPS outlook by 10c to $4.20. The analyst cites the "continued strength in profitability within both Japanese and US operations and sustained share buybacks" for Aflac, but also sees its risks and rewards as "fairly balanced" at current levels, keeping a Hold rating on the shares.
01/02/19
JPMS
01/02/19
DOWNGRADE
Target $51
JPMS
Neutral
Aflac downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Jimmy Bhullar downgraded Aflac to Neutral with an unchanged price target of $51. The analyst forecasts insurers to generate "healthy" margins in their foreign businesses, especially in Japan, but he adds that "lackluster" sales and negative currency moves present headwinds. He points out that Aflac has the most exposure to international markets among the names he covers.
12/31/18
ARGS
12/31/18
UPGRADE
Target $39
ARGS
Buy
Sun Life Financial upgraded to Buy at Argus on valuation
Argus analyst Jacob Kilstein upgraded Sun Life Financial (SLF) to Buy from Hold with a price target of $39, saying the company's valuation has become attractive after an 18% decline in the stock price since his last published report. The analyst cites Sun Life Financial's consistently strong earnings and above peer average ROE, along with some of its recent "small acquisitions" that should boost its earnings. Kilstein adds that his price target on the stock implies a forward earnings multiple of 10.5-times, which is still below the peer average of 11.7% valuation seen in the likes of Aflac (AFL) and Primerica (PRI).

TODAY'S FREE FLY STORIES

GLD

SPDR Gold Shares

$140.47

-0.13 (-0.09%)

17:52
10/18/19
10/18
17:52
10/18/19
17:52
Hot Stocks
SPDR Gold Shares holdings rise to 924.64MT from 918.19MT »

This is the first…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TECK

Teck Resources

$16.48

0.11 (0.67%)

17:43
10/18/19
10/18
17:43
10/18/19
17:43
Hot Stocks
Teck Resources gets approval for stock buyback for up to 40M class B shares »

Teck Resources has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

OSK

Oshkosh

$77.22

0.46 (0.60%)

17:41
10/18/19
10/18
17:41
10/18/19
17:41
Hot Stocks
Oshkosh awarded $159.14M Army contract for medium tactical vehicle production »

Oshkosh was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 19

    Nov

  • 20

    Nov

OVLY

Oak Valley Bancorp

$16.40

-0.16 (-0.97%)

17:35
10/18/19
10/18
17:35
10/18/19
17:35
Earnings
Oak Valley Bancorp reports Q3 EPS 40c vs. 37c last year »

Reports Q3 NII $10.4M vs.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTNW

FTE Networks

$0.79

-0.0185 (-2.29%)

17:21
10/18/19
10/18
17:21
10/18/19
17:21
Hot Stocks
FTE Networks receives noncompliance notice from NYSE American »

FTE Networks announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNXP

Tonix Pharmaceuticals

$0.45

0.0048 (1.07%)

17:12
10/18/19
10/18
17:12
10/18/19
17:12
Syndicate
Breaking Syndicate news story on Tonix Pharmaceuticals »

Tonix Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RLMD

Relmada Therapeutics

$20.18

1.07 (5.60%)

17:10
10/18/19
10/18
17:10
10/18/19
17:10
Syndicate
Breaking Syndicate news story on Relmada Therapeutics »

Relmada Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:55
10/18/19
10/18
16:55
10/18/19
16:55
General news
Breaking General news story  »

Dallas Federal Reserve…

NWSA

News Corp.

$13.48

-0.19 (-1.39%)

, NWS

News Corp

$13.79

-0.11 (-0.79%)

16:51
10/18/19
10/18
16:51
10/18/19
16:51
Periodicals
Facebook reaches pact with News Corp., others for news section, WSJ says »

News Corp. (NWSA) has…

NWSA

News Corp.

$13.48

-0.19 (-1.39%)

NWS

News Corp

$13.79

-0.11 (-0.79%)

FB

Facebook

$185.96

-4.435 (-2.33%)

NYT

New York Times

$29.76

0.21 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

  • 06

    Nov

WAIR

Wesco Aircraft

$11.01

0.01 (0.09%)

16:46
10/18/19
10/18
16:46
10/18/19
16:46
Conference/Events
Wesco Aircraft to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

FOMX

Foamix

$3.15

-0.09 (-2.78%)

16:41
10/18/19
10/18
16:41
10/18/19
16:41
Hot Stocks
Breaking Hot Stocks news story on Foamix »

Foamix up 7.5% at $3.35…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 20

    Oct

POAI

Predictive Oncology

$0.44

0.0101 (2.35%)

16:40
10/18/19
10/18
16:40
10/18/19
16:40
Conference/Events
Predictive Oncology to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BK

BNY Mellon

$45.34

0.975 (2.20%)

16:40
10/18/19
10/18
16:40
10/18/19
16:40
Hot Stocks
BNY Mellon SVP Harris sells 50K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOMX

Foamix

$3.15

-0.09 (-2.78%)

16:40
10/18/19
10/18
16:40
10/18/19
16:40
Hot Stocks
Breaking Hot Stocks news story on Foamix 

Foamix trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 20

    Oct

BAC

Bank of America

$30.37

0.1 (0.33%)

16:35
10/18/19
10/18
16:35
10/18/19
16:35
Hot Stocks
Bank of America's Knox sells 40,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 15

    Jan

LGC

Legacy Acquisition Corp

$10.24

0.02 (0.20%)

16:34
10/18/19
10/18
16:34
10/18/19
16:34
Conference/Events
Legacy Acquisition Corp to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MFGP

Micro Focus

$15.13

0.56 (3.84%)

, OTEX

OpenText

$39.30

-1.545 (-3.78%)

16:33
10/18/19
10/18
16:33
10/18/19
16:33
Periodicals
OpenText weighing takeover bid for rival Micro Focus, Bloomberg says »

Open Text (OTEX) is…

MFGP

Micro Focus

$15.13

0.56 (3.84%)

OTEX

OpenText

$39.30

-1.545 (-3.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 06

    Nov

  • 19

    Nov

16:30
10/18/19
10/18
16:30
10/18/19
16:30
Options
Preliminary option volume of 21.9M today »

Preliminary option volume…

BA

Boeing

$344.01

-25.12 (-6.81%)

, ORCL

Oracle

$54.55

-0.52 (-0.94%)

16:22
10/18/19
10/18
16:22
10/18/19
16:22
On The Fly
Fly Intel: Wall Street's top stories for Friday »

U.S. earnings have…

BA

Boeing

$344.01

-25.12 (-6.81%)

ORCL

Oracle

$54.55

-0.52 (-0.94%)

KO

Coca-Cola

$54.78

0.98 (1.82%)

AXP

American Express

$116.82

-2.35 (-1.97%)

JNJ

Johnson & Johnson

$127.73

-8.47 (-6.22%)

M

Macy's

$15.11

-0.66 (-4.19%)

LB

L Brands

$16.32

-1.78 (-9.83%)

GPS

Gap

$16.87

-0.71 (-4.04%)

LEVI

Levi Strauss

$17.12

0.07 (0.41%)

DERM

Dermira

$7.17

1.49 (26.23%)

ETFC

E-Trade

$40.82

1.78 (4.56%)

GIL

Gildan Activewear

$26.29

-9.085 (-25.68%)

TEAM

Atlassian

$116.96

-5.47 (-4.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 23

    Oct

  • 27

    Oct

  • 31

    Oct

  • 13

    Nov

  • 19

    Nov

  • 19

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 06

    Dec

  • 07

    Dec

EYEG

EyeGate

$3.40

(0.00%)

16:20
10/18/19
10/18
16:20
10/18/19
16:20
Syndicate
Breaking Syndicate news story on EyeGate »

EyeGate files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
10/18/19
10/18
16:20
10/18/19
16:20
Options
Closing CBOE SPX and VIX Index summary for October 18th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTOR

Meritor

$20.36

0.36 (1.80%)

16:17
10/18/19
10/18
16:17
10/18/19
16:17
Hot Stocks
Glenview Capital discloses 14.7% activist stake in Meritor »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

BCBP

BCB Bancorp

$12.91

-0.04 (-0.31%)

16:17
10/18/19
10/18
16:17
10/18/19
16:17
Earnings
BCB Bancorp reports Q3 EPS 30c, consensus 30c »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
10/18/19
10/18
16:17
10/18/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
10/18/19
10/18
16:16
10/18/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.